{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:11:52Z","timestamp":1793121112540,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.tiv.2021.105199","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T02:37:36Z","timestamp":1622860656000},"page":"105199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pharmacological evaluation of innovative eye drop formulations containing TS-polysaccaride, hyaluronic acid and glycyrrhizin for irritative ocular diseases using in vitro reconstituted human corneal epithelium model"],"prefix":"10.1016","volume":"75","author":[{"given":"Valentina","family":"Citi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Neggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sans\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Calderone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2021.105199_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tiv.2015.11.012","article-title":"Multi-laboratory validation of SkinEthic HCE test method for testing serious eye damage\/eye irritation using liquid chemicals","volume":"31","author":"Alepee","year":"2016","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2021.105199_bb0010","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0161-6420(98)98026-5","article-title":"A randomized clinical trial of the nonsteroidal eyedrop diclofenac after strabismus surgery","volume":"105","author":"Apt","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.tiv.2021.105199_bb0015","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2147\/OPTH.S186074","article-title":"Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study","volume":"12","author":"Burillon","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.tiv.2021.105199_bb0020","doi-asserted-by":"crossref","first-page":"15210","DOI":"10.1038\/s41598-020-72295-x","article-title":"Ocular surface inflammation induces de novo expression of substance P in the trigeminal primary afferents with large cell bodies","volume":"10","author":"Byun","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2021.105199_bb0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/OPTH.S229879","article-title":"Eye irritation potential of microglycine and microglycine-containing ointments: an in vitro study on reconstructed human corneal epithelium","volume":"14","author":"Ceriotti","year":"2020","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.tiv.2021.105199_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/mps3040074","article-title":"Development of in vitro corneal models: opportunity for pharmacological testing","volume":"3","author":"Citi","year":"2020","journal-title":"Meth. Protoc."},{"key":"10.1016\/j.tiv.2021.105199_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.tiv.2021.105199_bb0040","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1167\/iovs.16-20903","article-title":"The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells","volume":"58","author":"Datta","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tiv.2021.105199_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12010022","article-title":"Polysaccharides in ocular drug delivery","volume":"12","author":"Dubashynskaya","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tiv.2021.105199_bb0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/jop.2008.0140","article-title":"Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells","volume":"25","author":"Epstein","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2021.105199_bb0055","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/AEM.65.8.3727-3729.1999","article-title":"The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities","volume":"65","author":"Freimoser","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.tiv.2021.105199_bb0060","doi-asserted-by":"crossref","first-page":"104604","DOI":"10.1016\/j.tiv.2019.104604","article-title":"Establishment and performance assessment of an in-house 3D Reconstructed Human Cornea-Like Epithelium (RhCE) as a screening tool for the identification of liquid chemicals with potential eye hazard","volume":"61","author":"Garcia","year":"2019","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2021.105199_bb0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/09273948.2016.1277247","article-title":"Roles of IL-6 in ocular inflammation: a review","volume":"26","author":"Ghasemi","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"Suppl. 2","key":"10.1016\/j.tiv.2021.105199_bb0070","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/ICL.0000000000000668","article-title":"Role of matrix metalloproteinase 9 in ocular surface disorders","volume":"46","author":"Jamerson","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.tiv.2021.105199_bb0075","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5487\/TR.2015.31.2.105","article-title":"Safety evaluation of polyethylene glycol (PEG) compounds for cosmetic use","volume":"31","author":"Jang","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.tiv.2021.105199_bb0080","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1167\/iovs.18-23944","article-title":"New human organotypic corneal tissue model for ophthalmic drug delivery studies","volume":"59","author":"Kaluzhny","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tiv.2021.105199_bb0085","doi-asserted-by":"crossref","first-page":"479","DOI":"10.14573\/altex.1608081","article-title":"From in vivo to in vitro: the medical device testing paradigm shift","volume":"34","author":"Kerecman Myers","year":"2017","journal-title":"ALTEX"},{"key":"10.1016\/j.tiv.2021.105199_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.tiv.2018.12.003","article-title":"Me-too validation study for in vitro eye irritation test with 3D-reconstructed human cornea epithelium, MCTT HCE(TM)","volume":"55","author":"Lim","year":"2019","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2021.105199_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12060570","article-title":"Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation","volume":"12","author":"Mazet","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.tiv.2021.105199_bb0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.14573\/altex.1807041","article-title":"Animal testing and its alternatives - the most important omics is economics","volume":"35","author":"Meigs","year":"2018","journal-title":"ALTEX"},{"key":"10.1016\/j.tiv.2021.105199_bb0105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pds.4859","article-title":"EU postmarket surveillance plans for medical devices","volume":"28","author":"Pane","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.tiv.2021.105199_bb0110","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/ptr.6178","article-title":"Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review","volume":"32","author":"Pastorino","year":"2018","journal-title":"Phytother. Res."},{"key":"10.1016\/j.tiv.2021.105199_bb0115","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.tiv.2021.105199_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.optm.2010.08.003","article-title":"A review of hyaluronan and its ophthalmic applications","volume":"82","author":"Rah","year":"2011","journal-title":"Optometry"},{"key":"10.1016\/j.tiv.2021.105199_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2415-7-5","article-title":"Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study","volume":"7","author":"Rolando","year":"2007","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.tiv.2021.105199_bb0130","first-page":"1055","article-title":"Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study","volume":"29","author":"Saeed","year":"2013","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.tiv.2021.105199_bb0135","doi-asserted-by":"crossref","first-page":"8438101","DOI":"10.1155\/2018\/8438101","article-title":"Inhibitory effects of Glycyrrhiza glabra and its major constituent glycyrrhizin on inflammation-associated corneal neovascularization","volume":"2018","author":"Shah","year":"2018","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.tiv.2021.105199_bb0140","doi-asserted-by":"crossref","first-page":"108523","DOI":"10.1016\/j.exer.2021.108523","article-title":"Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study","volume":"205","author":"Shoari","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.tiv.2021.105199_bb0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/jop.2020.0105","article-title":"Effects of glycyrrhizin treatment on diabetic cornea","volume":"37","author":"Somayajulu","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2021.105199_bb0150","first-page":"20","article-title":"Hyaluronic acid combined with serum rich in growth factors in corneal epithelial defects","author":"Suarez-Barrio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tiv.2021.105199_bb0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.sjopt.2014.06.006","article-title":"Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives","volume":"28","author":"Tu","year":"2014","journal-title":"Saudi J. Ophthalmol."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233321001247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233321001247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:38:46Z","timestamp":1760135926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233321001247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":31,"alternative-id":["S0887233321001247"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105199","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological evaluation of innovative eye drop formulations containing TS-polysaccaride, hyaluronic acid and glycyrrhizin for irritative ocular diseases using in vitro reconstituted human corneal epithelium model","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2021.105199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105199"}}